bioRxiv ScienceSearch

bioRxiv · 10.1101/275727

Visual encoding signals around 200 milliseconds track onset of evidence accumulation during human decision making

Abstract

Encoding of a sensory stimulus is believed to be the first step in perceptual decision making. Previous research has shown that electrical signals recorded from the human brain track evidence accumulation during perceptual decision making (Gold and Shadlen, 2007; OConnell et al., 2012; Philiastides et al., 2014). In this study we directly tested the hypothesis that the latency of the N200 recorded by EEG (a negative peak occurring between 150 and 275 ms after stimulus presentation in human participants) reflects the visual encoding time (VET) required for completion of figure-ground segregation before evidence accumulation. We show that N200 latencies vary across individuals, are modulated by external visual noise, and increase response time by x milliseconds when they increase by x milliseconds, reflecting a linear regression slope of 1. Simulations of cognitive decision-making theory show that variation in human response times not related to evidence accumulation (including VET) are tracked by the fastest response times. A relationship with a slope of 1 between N200 latencies and VET was found by fitting a linear model between trial-averaged N200 latencies and the 10th percentiles of response times. A slope of 1 was also found between single-trial N200 latencies and response times. Fitting a novel neuro-cognitive model of decision-making also yielded a slope of 1 between N200 latency and non-decision time in multiple visual noise conditions, indicating that N200 latencies track the completion of visual encoding and the onset of evidence accumulation. The N200 waveforms were localized to the cortical surface at distributed temporal and extrastriate locations, consistent with a distributed network engaged in figure-ground segregation of the target stimulus.\n\nSignificance StatementEncoding of a sensory stimulus is believed to be the first step in perceptual decision making. In this study, we report evidence that visual evoked potentials (EPs) around 200 ms after stimulus presentation track the time of visual figure-ground segregation before the onset of evidence accumulation during decision making. These EP latencies vary across individuals, are modulated by external visual noise, and increase response time by x milliseconds when they increase by x milliseconds. Hierarchical Bayesian model-fitting was also used to relate these EPs to a specific cognitive parameter that tracks time related to visual encoding in a decision-making model of response time. This work adds to the growing literature that suggests that EEG signals can track the component cognitive processes of decision making.

Source connections

Explore related subjects

Keep this discovery

BibTeXRIS

Nunez, M. D., Gosai, A., Vandekerckhove, J., Srinivasan, R.. 2018-03-03. Visual encoding signals around 200 milliseconds track onset of evidence accumulation during human decision making. https://doi.org/10.1101/275727

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience